Evidence map›Paper›PMID 40487839›Full record

ReviewFrontiers in radiology2025

Use of artificial intelligence in the management of stroke: scoping review.

Nicolas Melo Sierra, Erwin Hernando Hernández Rincón, Gabriela Alejandra Osorio Betancourt, Paula Andrea Ramos Chaparro, Diana Marcela Diaz Quijano, Samuel David Barbosa, Michel Hernandez Restrepo, Gustavo Uriza Sinisterra

Abstract readReview
In one paragraph

Review in Frontiers in radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nicolas Melo SierraFaculty of Medicine, Universidad de La Sabana, Chía, Colombia.
Erwin Hernando Hernández RincónDepartment of Family Medicine and Public Health, Universidad de La Sabana, Chía, Colombia.
Gabriela Alejandra Osorio BetancourtFaculty of Medicine, Universidad de La Sabana, Chía, Colombia.
Paula Andrea Ramos ChaparroFaculty of Medicine, Universidad de La Sabana, Chía, Colombia.
Diana Marcela Diaz QuijanoDepartment of Epidemiology, Universidad de la Sabana, Chia, Colombia.
Samuel David BarbosaFaculty of Medicine, Universitat Oberta Catalunya, Barcelona, Spain.
Michel Hernandez RestrepoDepartment of Radiology, Hospital Universitario de La Samaritana, Bogotá, Colombia.
Gustavo Uriza SinisterraDepartment of Neurosurgery, Clínica Universidad de La Sabana, Chía, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Stroke is a condition that is more predominant in developed countries. However, it continues to be considered a high-cost health pathology worldwide, both in the medium and long term. Therefore, diagnosis, treatment, and rehabilitation are vital. Additionally, the assistance of artificial intelligence in these three principles has been increasing, given its effectiveness and efficiency in performance. Objective: This study analyzes the available evidence regarding the use of artificial intelligence in primary care for stroke patients. Methods: A scoping review was conducted on three indexed databases, Science Direct, Web of Science, and PubMed, resulting in the identification of 1,382 articles. Initially, these terms were filtered on the basis of the year of publication and language. A second distinction was subsequently made through the title and abstract of each publication. Results: A total of 33 articles summarizing 5 categories were selected: healthcare from a general point of view; stroke prediction; the diagnosis and treatment of both stroke and its sequelae; the risk of death in the poststroke period; and the assistance of AI in some specialties related to the disease. Conclusion: Artificial intelligence has the potential to improve stroke care, but more research is still needed to evaluate its performance in clinical practice. Introducción: El accidente cerebrovascular es una condición predominante en los países desarrollados. A pesar de esto, es una patología de salud de alto costo en todo el mundo, tanto a mediano como a largo plazo. Por lo tanto, el diagnóstico, el tratamiento y la rehabilitación son de vital importancia. Por lo anterior, la asistencia de la inteligencia artificial en estos tres principios ha ido en aumento, dada su eficacia y eficiencia en el desempeño. Objetivo: Este estudio analiza la evidencia disponible sobre el uso de la Inteligencia Artificial en la atención primaria para el accidente cerebrovascular. Métodos: Se realizó una revisión tipo Scoping Review en tres bases de datos indexadas: Science Direct, Web of Science y PubMed, lo que resultó en la identificación de 1,382 artículos. Inicialmente, estos se filtraron en función del año de publicación y el idioma. Posteriormente, se realizó una segunda distinción a través del título y el resumen de cada publicación. Resultados: Se seleccionaron un total de 33 artículos, que se seleccionaron en 5 categorías: atención médica desde un punto de vista general; predicción de accidente cerebrovascular; diagnóstico y tratamiento tanto del accidente cerebrovascular como de sus secuelas; riesgo de muerte en el período posterior al accidente cerebrovascular; y finalmente, la asistencia de la Inteligencia Artificial en algunas especialidades relacionadas con la enfermedad. Conclusión: La Inteligencia Artificial tiene el potencial de mejorar la atención del accidente cerebrovascular, pero aún se necesitan más investigaciones para evaluar su desempeño en la práctica clínica.

Indexed as

artificial intelligencehemorrhagic strokeischemic strokemachine learning algorithmsprimary health care

Identifiers

PMID40487839
PMCPMC12141347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.